Advertisement

Nitrates III pp 461-468 | Cite as

General Principles of Treatment with Vasodilators

  • J. N. Cohn
Conference paper

Abstract

The remarkable hemodynamic response to the administration of a vasodilator drug in patients with left ventricular failure was first demonstrated in an organized fashion in 1971 and 1972 [14, 22]. In the few years since these early clinical observations successfully confirmed experimental concepts [2, 20], vasodilator drug therapy has become an important mode of therapy for patients with severe congestive heart failure [4, 6]. Despite widespread clinical use, however, experience with these drugs has still been of too short duration, involved too limited numbers, and has been too poorly controlled to provide a satisfactory basis for choosing patients and drugs in a vasodilator treatment regimen. The rapid expansion of experience with this form of therapy is leading to new insights that should eventually place such therapy on a rational basis. Furthermore, new and hopefully more potent vasodilator drugs are being developed that may not only be more effective but may allow selectivity of the mechanism of action that will provide an opportunity for tailoring therapy for individual patients with congestive heart failure.

Keywords

Isosorbide Dinitrate Vasodilator Therapy Chronic Congestive Heart Failure Left Ventricular Failure Left Ventric 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aronow WS, Danahy DT (1978) Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure. Am J Med 65: 155PubMedCrossRefGoogle Scholar
  2. 2.
    Awan NA, Miller RR, De Maria AN, Maxwell KS, Neumann A, Mason DT (1977) Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Circulation 56: 346PubMedGoogle Scholar
  3. 3.
    Chatteijee K, Ports T, Rubin S, Massie B, Arnold S, Brundage B, Parmley W (1978) Sustained beneficial hemodynamic effects during long-term hydralazine therapy in patients with chronic heart failure. Circulation 58: 11–28Google Scholar
  4. 4.
    Cohn JN (1973) Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance. Circulation 47: 5Google Scholar
  5. 5.
    Cohn JN (1974) A new look at indications for digitalis therapy. JAMA 229: 1911–1914PubMedCrossRefGoogle Scholar
  6. 6.
    Cohn JN, Franciosa JA (1977) Vasodilator therapy of cardiac failure. N Engl J Med 297: 254PubMedCrossRefGoogle Scholar
  7. 7.
    Cohn JN, Franciosa J A (1978) Selection of vasodilator, inotropic or combined therapy for the management of heart failure. Am J Med 65: 181–188PubMedCrossRefGoogle Scholar
  8. 8.
    Cohn JN, Taylor N, Vrobel T, Moskowitz R (1978) Contrasting effect of vasodilators on heart rate and plasma catecholamines in patients with hypertension and heart failure. Clin Res 26:547 AGoogle Scholar
  9. 9.
    Colucci WS, Wynne J, Holman BL, Braunwald E (1980) Long-term therapy of heart failure with prazosin: A randomized double blind trial. Am J Cardiol 45: 337Google Scholar
  10. 10.
    Curtiss C, Cohn JN, Vrobel T, Franciosa JA (1978) Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation 58: 763PubMedGoogle Scholar
  11. 11.
    Franciosa J A, Cohn JN (1978) Hemodynamic effects of trimazosin in patients with left ventricular failure. Clin Pharmacol Ther 23: 11PubMedGoogle Scholar
  12. 12.
    Franciosa JA, Cohn JN (1979) Immediate effects of hydralazine-isosorbide dinitrate combination on exercise capacity and exercise hemodynamics in patients with left ventricular failure. Circulation 59: 1085PubMedGoogle Scholar
  13. 13.
    Franciosa J A, Cohn JN (1980) Sustained hemodynamic effect without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. Am J Cardiol 45: 648PubMedCrossRefGoogle Scholar
  14. 14.
    Franciosa J A, Guiha NH, Limas CJ, Rodriguera E, Cohn JN (1972) Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet 1: 650PubMedCrossRefGoogle Scholar
  15. 15.
    Franciosa J A, Pierpont G, Cohn JN (1977) Hemodynamic improvement after oral hydralazine in left ventricular failure: A comparison with nitroprusside infusion in 16 patients. Ann Intern Med 86: 388PubMedGoogle Scholar
  16. 16.
    Franciosa JA, Blank RC, Cohn JN (1978) Nitrate effects on cardiac output and left ventricular outflow resistance in chronic congestive heart failure. Am J Med 64: 207PubMedCrossRefGoogle Scholar
  17. 17.
    Franciosa JA, Goldsmith SR, Cohn JN (to be published) Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure. Am J MedGoogle Scholar
  18. 18.
    Goodman DJ, Rossen RM, Holloway EL, Alderman EL, Harrison DC (1974) Effects of nitroprusside on left ventricular dynamics in mitral regurgitation. Circulation 50: 1025PubMedGoogle Scholar
  19. 19.
    Guiha NH, Cohn JN, Mikulic E, Franciosa JA, Limas CJ (1974) Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med 291: 587PubMedCrossRefGoogle Scholar
  20. 20.
    Imperial ES, Levy MN, Zieske H Jr (1961) Outflow resistance as an independent determinant of cardiac performance. Circ Res 9: 1148Google Scholar
  21. 21.
    Levine TB, Franciosa JA, Cohn JN (1980) Acute and long-term response to an oral converting- enzyme inhibitor, Captopril, in congestive heart failure. Circulation 62: 35–41Google Scholar
  22. 22.
    Majid PA, Sharma B, Taylor SH (1971) Phentolamine for vasodilator treatment of severe heart failure. Lancet 11: 720Google Scholar
  23. 23.
    Mikulic E, Franciosa JA, Cohn JN (1975) Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure. Circulation 52: 477PubMedGoogle Scholar
  24. 24.
    Miller RR, Vismara LA, Williams DO, Amsterdam EA, Mason DT (1976) Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure: Differential effects of nitroprusside, phentolamine and nitroglycerin on cardiac function and peripheral circulation. Circ Res 39: 127Google Scholar
  25. 25.
    Miller RR, Awan NA, Maxwell KS, Mason DT (1977) Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator, prazosin. N Eng J Med 297: 303CrossRefGoogle Scholar
  26. 26.
    Milnor WR (1975) Arterial impedance as ventricular afterload. Circ Res 36: 565PubMedGoogle Scholar
  27. 27.
    Packer M, Melier J, Gorlin R, Herman MV (1979) Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure. Circulation 59: 531PubMedGoogle Scholar
  28. 28.
    Pierpont GL, Cohn JN, Franciosa JA (1978) Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. Chest 73: 8Google Scholar
  29. 29.
    Rubin SA, Chatterjee K, Ports TA, Gelberg HJ, Brundage BH, Parmley WW (1979) Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure. Am J Cardiol 44: 1183PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1981

Authors and Affiliations

  • J. N. Cohn

There are no affiliations available

Personalised recommendations